Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus (Q37812288)

23 August 2017

Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

23 August 2017

0 references

0 references

author

Hai-Feng Pan

2

0 references

author name string

Jing Li

1

1 reference

23 August 2017

Han Cen

3

1 reference

23 August 2017

Jing Tian

4

1 reference

23 August 2017

Yan Ma

5

1 reference

23 August 2017

Jin-Hui Tao

6

1 reference

23 August 2017

Dong-Qing Ye

7

1 reference

23 August 2017

24 November 2010

1 reference

Molecular Biology Reports

23 August 2017

1 reference

23 August 2017

38

1 reference

23 August 2017

6

1 reference

23 August 2017

4077-4081

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-010-0527-y

23 August 2017

0 references

cites work

Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

A polymorphism within IL21R confers risk for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Interleukin-21 as a new therapeutic target for immune-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-21 administration into the nostril alleviates murine allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

The role of IL-21 in regulating B-cell function in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Biology of IL-21 and the IL-21 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Interleukin 21: a cytokine/cytokine receptor system that has come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Cytokine requirements for the growth and development of mouse NK cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

The molecular basis of IL-21-mediated proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

B cell abnormalities in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0527-Y

A Functional Role for Interleukin-21 in Promoting the Synthesis of the T-Cell Chemoattractant, MIP-3α, by Gut Epithelial Cells

21 January 2018

1 reference

12 December 2020

Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.

1 reference

12 December 2020

Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus

1 reference

12 December 2020

A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus

1 reference

12 December 2020

10.1007/S11033-010-0527-Y

Identifiers

DOI

1 reference

23 August 2017

1 reference